IRS2 and neoplasm: The contributions of IRS2 to tumor cell biology have been revealed through studies using cell and mouse model systems in which the IRS2 gene has been genetically knocked out by Cre-lox recombination or CRISPR/Cas9-mediated gene editing or knocked down by shRNA (1, 11, 12, 25).